Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenyang SinQi Eye Hospital is a specialized ophthalmic medical institution located in Shenyang, China, and is a wholly-owned subsidiary of Shenyang Sinqi Pharmaceutical. The hospital serves as a critical clinical and commercial hub for the parent company's ophthalmic products, most notably its low-concentration atropine eye drops used for myopia control in children. Beyond providing comprehensive eye care services, the hospital has played a significant role in the real-world application and distribution of Sinqi's pharmaceutical innovations through its internet hospital platform. It integrates clinical treatment, ophthalmic research, and pharmaceutical dispensing to address the growing prevalence of vision disorders in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyang SinQi Eye Hospital.